Exposure to uncontrolled fire, not in building or structure

VWXY20_EXPOS_UNCONT_FIRE_NOT_BUILD_STRUCTURE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X01 Cause of death: ICD-10 — X01 2 out of 7 registries used, show all original rules.	82
4. Check minimum number of events None	82
5. Include endpoints None	82
6. Filter based on genotype QC (FinnGen only)	80

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X0

NAME	VWXY20_EXPOS_UNCONT_FIRE_NOT_BUILD_STRUCTURE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X01
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X01
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Exposure to uncontrolled fire, not in building or structure based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	80	37	43
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	51.97	51.58	52.31

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
82: Matched controls
820

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X01

ICD-10 Finland

Exposure to uncontrolled fire, not in building or structure

+∞

112.5

T20.2

ICD-10 Finland

Burn of second degree of head and neck

+∞

18.4

ZZA00

NOMESCO Finland

Split skin graft

52.0

17.3

QCD20

NOMESCO Finland

Excision of burn of upper limb and coverage

195.8

16.1

T23.2

ICD-10 Finland

Burn of second degree of wrist and hand

48.9

13.7

S14

ICPC

Burn/scald

17.2

12.8

QBD20

NOMESCO Finland

Excision of burn of trunk and coverage

69.3

10.9

QDD00

NOMESCO Finland

Dressing of major burn of lower limb

+∞

10.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

5.8

10.0

QCD00

NOMESCO Finland

Dressing of major burn of upper limb

62.7

9.9

T31.0

ICD-10 Finland

Burns involving less than 10% of body surface

99.9

8.6

QDD20

NOMESCO Finland

Excision of burn of lower limb and coverage

99.9

8.6

X58

ICD-10 Finland

Exposure to other specified factors

4.7

8.5

T20.0

ICD-10 Finland

Burn of unspecified degree of head and neck

+∞

8.5

X09

ICD-10 Finland

Exposure to unspecified smoke, fire and flames

49.9

7.9

X00

ICD-10 Finland

Exposure to uncontrolled fire in building or structure

87.7

7.5

X59

ICD-10 Finland

Exposure to unspecified factor

4.0

7.4

T29.3

ICD-10 Finland

Burns of multiple regions, at least one burn of third degree mentioned

+∞

7.4

T31.1

ICD-10 Finland

Burns involving 10-19% of body surface

+∞

7.4

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

11.6

7.3

ZXD05

NOMESCO Finland

Urgent procedure

3.4

6.4

123

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.3

6.3

144

X03

ICD-10 Finland

Exposure to controlled fire, not in building or structure

+∞

6.3

QAD20

NOMESCO Finland

Excision of burn of head or neck and coverage

+∞

6.3

N05BA04

ATC

oxazepam; oral

3.4

6.2

119

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044640) Blood type and Crossmatch panel - Blood

194

3.23

6.35

3.5

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

304

2.94

5.24

3.2

2.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3.57

5.15

11.8

5.6

5.20

4.91

kpa

0.48

(3027801) Oxygen [Partial pressure] in Arterial blood

3.57

5.15

11.8

5.6

10.99

12.00

kpa

0.45

(3016502) Oxygen saturation in Arterial blood

3.56

4.94

12.3

5.9

94.56

95.80

0.43

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

148

2.91

4.94

2.8

2.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.46

4.91

3.3

1.7

—

(3000991) Gas panel - Venous blood

3.66

4.49

14.5

6.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

5.43

4.39

17.3

7.2

24.30

24.71

mmol/l

0.18

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4.60

4.36

2.7

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3.27

4.18

7.0

3.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

3.04

3.89

13.3

6.3

105.58

103.73

mmol/l

0.94

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4.08

3.46

1.8

1.3

—

(3025941) Bacteria identified in Stool by Culture

3.95

3.36

1.3

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3.10

3.17

4.8

2.3

9.39

9.60

g/l

0.09

(3042936) Bacteria identified in Isolate by Culture

2.68

3.13

4.7

2.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

10.52

3.02

1.6

1.8

—

(3023368) Bacteria identified in Blood by Culture

143

2.32

2.97

6.1

4.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

262

2.13

2.83

8.9

4.6

35.26

36.60

g/l

0.68

250

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

8.77

2.78

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

8.77

2.78

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

139

2.27

2.78

2.0

2.2

1.50

1.09

mg/l

0.23

111

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

4.08

2.76

1.7

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3.27

2.61

19.0

6.8

93.63

93.78

0.04

(3034770) Mitochondria Ab [Titer] in Serum

4.40

2.42

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

4.40

2.42

1.1

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

275

1.98

2.37

20.7

13.0

1.39

1.16

inr

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

4.15

2.31

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

4.15

2.31

1.1

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

243

1.95

2.24

5.2

3.4

23.36

36.37

ng/l

0.63

155

(3028626) Oxygen [Partial pressure] in Capillary blood

5.83

2.24

2.4

2.6

6.78

8.03

kpa

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

5.24

2.10

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

5.24

2.10

1.2

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

3.54

2.01

5.0

2.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

479

1.94

1.88

5.6

3.0

58.04

41.14

u/l

1.32

450

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

4.36

1.85

1.0

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

4.36

1.85

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

195

1.85

1.81

5.8

3.4

2.35

mmol/l

0.04

171

(3026008) Bacteria identified in Urine by Culture

154

1.90

1.77

3.9

2.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.38

1.77

1.6

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

4.02

1.74

1.4

2.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

4.02

1.74

3.6

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2.96

1.69

1.1

—

(3022313) Gas panel - Capillary blood

2.66

1.64

2.3

3.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.61

1.53

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2.39

1.53

3.0

6.4

23.08

24.60

mmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

104

1.94

1.52

1.6

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.53

1.51

23.6

6.0

—

(3016879) Cocaine [Presence] in Urine

2.40

1.45

4.1

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

106

1.89

1.44

3.4

3.6

44.27

558.18

ng/l

0.93

(3000330) Specific gravity of Urine by Test strip

2.54

1.42

6.0

3.6

—

(3027944) Amphetamines [Presence] in Urine

2.34

1.42

4.1

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

2.34

1.42

4.1

1.7

—

(3028300) Cannabinoids [Presence] in Urine

2.34

1.42

4.1

1.7

—

(3027008) Opiates [Presence] in Urine

2.34

1.42

4.1

1.7

—

(3003694) ABO and Rh group [Type] in Blood

191

1.71

1.39

1.4

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.42

1.31

7.0

6.5

23.79

24.29

mmol/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

160

1.71

1.29

1.4

1.3

0.63

1.01

u/ml

0.51

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.35

1.28

4.5

1.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

103

1.82

1.25

2.8

2.7

0.98

0.88

e6/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.00

1.13

1.7

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2.00

1.13

1.5

1.8

338.09

381.73

nmol/l

0.45

(3002582) Erythrocytes [#/volume] in Urine

183

1.62

1.13

4.0

3.0

45.37

43.20

e6/l

0.03

140

(40758558) Short blood count panel - Blood

157

1.65

1.12

11.5

6.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.30

1.11

1.3

2.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2.47

1.10

1.2

1.8

10.68

9.68

mg/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

212

1.57

1.07

3.6

3.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.93

1.04

1.8

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

215

0.58

1.03

3.4

4.1

21.94

22.03

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

102

1.71

1.00

11.6

3.9

0.79

0.82

mmol/l

0.90

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

182

1.54

0.93

3.2

2.1

273.28

200.21

u/l

0.36

174

(3018095) Leukocytes [#/volume] in Urine

212

1.49

0.87

4.7

3.5

210.22

26.93

e6/l

0.56

148

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.65

0.86

3.6

2.7

2.90

3.29

e6/l

—

(3022621) pH of Urine by Test strip

1.82

0.85

6.9

2.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.80

0.0

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.80

0.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.80

0.0

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.80

0.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.80

0.0

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

126

1.55

0.79

1.7

1.8

—

(3045414) Leukocytes [Presence] in Urine

2.25

0.77

1.4

1.8

—

(3049717) Cytology report of Urine Cyto stain

2.15

0.76

2.4

2.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

236

1.43

0.75

1.9

1.8

86.12

97.03

pmol/l

0.80

114

(4200892) Spirometry reversibility

1.82

0.73

1.1

1.4

—

(3019060) Gas panel - Arterial blood

1.77

0.72

2.1

4.5

—

(3020891) Body temperature

1.98

0.72

2.8

4.7

—

(3011288) Drugs identified in Urine by Screen method

1.91

0.69

4.8

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.69

0.69

4.9

4.4

1.22

mmol/l

—

(3030467) Casts [#/volume] in Urine by Automated count

167

1.43

0.66

3.3

2.9

0.15

0.19

e6/l

0.22

123

(3037467) Urinalysis macro (dipstick) panel - Urine

447

1.37

0.65

5.6

3.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.59

0.64

2.1

1.8

—

(3022145) Colonoscopy Study observation

1.61

0.63

1.1

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.61

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.61

0.0

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.59

0.0

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.59

0.0

1.4

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.59

0.0

1.4

—

(3002256) Pathology report gross observation

1.61

0.58

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

688

1.56

0.58

29.8

11.4

23.21

21.97

mg/l

0.13

508

(36304419) Bacteria [Presence] in Urine

162

1.40

0.58

3.2

2.8

—

(3021589) Normoblasts [#/volume] in Blood

285

1.33

0.56

20.0

9.0

0.00

e9/l

0.50

230

(46235355) HIV 1 and 2 tests - Meaningful Use set

146

1.39

0.53

1.9

2.2

—

(3026782) Osmolality of Urine

112

1.42

0.49

5.5

2.9

562.60

601.00

mosm/kgh2o

0.28

100

(3020682) Albumin/Creatinine [Ratio] in Urine

196

1.32

0.46

3.2

3.9

2.57

11.52

mg/mmol

2.28

125

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.63

0.45

7.3

6.8

—

(40768793) Breast Pathology biopsy report

0.00

0.41

0.0

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

785

0.69

0.40

41.5

17.5

39.45

41.08

1.27

743

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.39

0.0

1.7

—

198.89

—

(3000850) Epithelial cells [#/volume] in Urine

117

1.35

0.38

3.1

2.5

3.99

3.48

e6/l

0.13

108

(40760892) CBC W Ordered Manual Differential panel - Blood

308

1.24

0.37

13.1

6.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.50

0.37

2.3

2.7

—

(3000494) Fungus identified in Specimen by Culture

1.42

0.36

1.9

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

193

1.27

0.36

7.3

2.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.43

0.36

5.7

3.9

4.44

4.55

pmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.39

0.35

1.2

1.0

—

(40761536) Microorganisms panel - Urine sediment

1.36

0.34

3.5

3.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1.28

0.28

4.3

2.2

14.69

13.38

nmol/l

—

(40768797) Stomach Pathology biopsy report

1.32

0.28

1.6

1.2

—

(3013512) EKG study

181

1.22

0.26

6.5

3.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.72

0.24

2.0

1.6

—

(1761868) Lipid panel - Serum or Plasma

270

0.84

0.24

3.7

2.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

107

1.26

0.23

1.7

1.2

12.16

31.34

iu/ml

—

(3019150) Specific gravity of Urine by Refractometry

155

1.21

0.22

6.3

3.3

1.02

kg/l

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

4.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

0.00

0.21

0.0

1.7

—

10.88

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

61.69

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.24

0.20

2.5

2.6

—

(40768800) Prostate Pathology biopsy report

0.00

0.20

0.0

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.23

0.19

5.9

4.7

43.69

9.84

ug/l

—

(40761511) CBC panel - Blood by Automated count

733

1.27

0.15

25.5

11.2

—

(40768804) Tissue Pathology biopsy report

252

0.88

0.15

1.7

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

260

1.12

0.13

7.2

3.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

147

0.86

0.12

2.8

3.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

144

1.14

0.11

1.6

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

323

1.09

0.09

6.5

3.3

0.00

estimate

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.08

0.09

1.2

1.5

—

(36660697) Celiac disease serology panel - Serum

1.06

0.09

1.2

—

(3019225) pH of Specimen

1.06

0.09

4.8

4.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

636

1.11

0.08

25.3

10.7

88.18

85.73

ml/min/173m2

0.37

506

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.84

0.07

1.9

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.84

0.07

1.9

2.0

—

(3044889) 12 lead EKG panel

464

0.93

0.07

4.6

3.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

102

1.09

0.03

1.5

1.2

1.04

4.50

u/ml

—

(3029937) Albumin [Presence] in Urine by Test strip

172

1.06

0.02

4.8

3.2

0.00

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

333

1.04

0.01

6.4

3.3

0.00

estimate

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

463

1.04

0.01

2.9

3.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

324

0.98

0.00

10.5

4.6

0.00

estimate

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

2.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

-0.00

0.0

2.2

—

3.70

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

2.0

—

6.79

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.5

—

965.83

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.1

—

8.95

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.2

—

(3025577) Chromium [Mass/volume] in Blood

0.00

-0.00

0.0

2.2

—

2.36

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3034426) Prothrombin time (PT)

0.00

-0.00

0.0

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

123.50

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

5.7

—

166.78

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

153.39

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

52.00

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

2.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.99

-0.00

1.8

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.90

-0.00

1.3

1.9

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

26.28

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

2.0

—

7.03

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

-0.00

0.0

1.6

—

12.80

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_EXPOS_UNCONT_FIRE_NOT_BUILD_STRUCTURE – Exposure to uncontrolled fire, not in building or structure

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Exposure to uncontrolled fire, not in building or structure

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Exposure to uncontrolled fire, not in building or structure (VWXY20_EXPOS_UNCONT_FIRE_NOT_BUILD_STRUCTURE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints